Evidence map›Paper›PMID 41681890›Full record

ArticleCancers2026

When Standards Meet Reality: An Inverted PORTEC-3 Protocol for High-Risk Endometrial Cancer in Resource-Limited Settings.

Raouia Ben Amor, Ines Mlayeh, Amal Riahi, Zeineb Naimi, Myriam Saadi, Rihab Haddad, Ghada Bouguerra, Awatef Hamdoun, Lilia Ghorbel, Nesrine Mejri Turki and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Raouia Ben AmorRadiation Oncology Departement, Abderrahmen Mami Hospital, Ariana 2080, Tunisia.
Ines MlayehRadiation Oncology Departement, Abderrahmen Mami Hospital, Ariana 2080, Tunisia.
Amal RiahiRadiation Oncology Departement, Abderrahmen Mami Hospital, Ariana 2080, Tunisia.
Zeineb NaimiRadiation Oncology Departement, Abderrahmen Mami Hospital, Ariana 2080, Tunisia.
Myriam SaadiFaculty of Medecine of Tunis, Tunis El Manar University, Tunis 1006, Tunisia.ORCID 0000-0001-5740-9411
Rihab HaddadRadiation Oncology Departement, Abderrahmen Mami Hospital, Ariana 2080, Tunisia.
Ghada BouguerraRadiation Oncology Departement, Abderrahmen Mami Hospital, Ariana 2080, Tunisia.
Awatef HamdounRadiation Oncology Departement, Abderrahmen Mami Hospital, Ariana 2080, Tunisia.
Lilia GhorbelRadiation Oncology Departement, Abderrahmen Mami Hospital, Ariana 2080, Tunisia.
Nesrine Mejri TurkiFaculty of Medecine of Tunis, Tunis El Manar University, Tunis 1006, Tunisia.
Lotfi KochbatiRadiation Oncology Departement, Abderrahmen Mami Hospital, Ariana 2080, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adjuvant chemoradiotherapybone marrow sparingdisease recurrenceendometrial cancerhematologic toxicityhigh-risk diseaseradiotherapy accesstreatment sequencing

Identifiers

PMID41681890
PMCPMC12896600

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.